A PHASE II STUDY OF AMRUBICIN AND CARBOPLATIN FOR PREVIOUSLY UNTREATED PATIENTS WITH EXTENSIVE-DISEASE SMALL CELL LUNG CANCER

被引：0
|
作者：
Ikeda, Takaya [1 ]
Taniguchi, Hirokazu [1 ]
Soda, Hiroshi [1 ]
Fukuda, Minoru [2 ]
Kinoshita, Akihito [3 ]
Fukuda, Masaaki [4 ]
Soejima, Yoshifumi [5 ]
Ogawara, Daiki [6 ]
Nakamura, Yoichi [6 ]
Kohno, Shigeru [6 ]
机构：
[1] Sasebo City Gen Hosp, Hirase, Sasebo, Japan
[2] Japanese Red Cross Nagasaki, Isahaya, Nagasaki, Japan
[3] Nagasaki Prefecture Shimabara Hosp, Shimabara, Nagasaki, Japan
[4] Natl Hosp, Org Nagasaki Med Ctr, Omura, Nagasaki, Japan
[5] Ureshino Med Ctr, Ureshina, Japan
[6] Nagasaki Univ Hosp, Dept Internal Med 2, Nagasaki, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
Extensive-Disease Small Cell Lung Cancer; amrubicin; chemotherapy; Carboplatin;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.10-005
引用
收藏
页码：S1157 / S1157
页数：1
相关论文
共 50 条
  • [21] Amrubicin monotherapy for elderly patients with relapsed extensive-disease small-cell lung cancer: A retrospective study
    Sone, Hideyuki
    Igawa, Satoshi
    Kasajima, Masashi
    Ishihara, Mikiko
    Hiyoshi, Yasuhiro
    Hosotani, Shinji
    Ohe, Shuntaro
    Ito, Hiroki
    Kaizuka, Nobuki
    Manaka, Hiroya
    Fukui, Tomoya
    Mitsufuji, Hisashi
    Kubota, Masaru
    Katagiri, Masato
    Sasaki, Jiichiro
    Naoki, Katsuhiko
    THORACIC CANCER, 2018, 9 (10) : 1279 - 1284
  • [22] Results of a Phase II study of carboplatin plus gemcitabine in patients with untreated extensive small cell lung cancer
    Neubauer, M
    Heaven, R
    Olivares, J
    Otsuka, A
    Paschold, E
    Sirridge, C
    Ilegbodu, D
    Tuttle, T
    Asmar, L
    LUNG CANCER, 2004, 46 (03) : 369 - 375
  • [23] A Randomized Phase III Study of Single-Agent Amrubicin Vs. Carboplatin/Etoposide in Elderly Patients With Extensive-Disease Small-Cell Lung Cancer
    Sekine, Ikuo
    Okamoto, Hiroaki
    Horai, Takeshi
    Nakagawa, Kazuhiko
    Ohmatsu, Hironobu
    Yokoyama, Akira
    Katakami, Nobuyuki
    Shibuya, Masahiko
    Saijo, Nagahiro
    Fukuoka, Masahiro
    CLINICAL LUNG CANCER, 2014, 15 (02) : 96 - 102
  • [24] A Phase 2 Study of Irinotecan, Cisplatin, and Simvastatin for Untreated Extensive-disease Small Cell Lung Cancer
    Han, Ji-Youn
    Lim, Kun Young
    Yu, Sun Young
    Yun, Tak
    Kim, Heung Tae
    Lee, Jin Soo
    CANCER, 2011, 117 (10) : 2178 - 2185
  • [25] Irinotecan plus carboplatin in patients with extensive-disease small-cell lung cancer
    Kim, Young Saing
    Park, Se Hoon
    Kyung, Sun Young
    Sym, Sun Jin
    Lee, Sang Pyo
    Park, Jeong Woong
    Jung, Sung Hwan
    Park, Jinny
    Cho, Eun Kyung
    Lee, Jae Hoon
    Shin, Dong Bok
    MEDICAL ONCOLOGY, 2011, 28 (01) : 342 - 350
  • [26] Irinotecan plus carboplatin in patients with extensive-disease small-cell lung cancer
    Young Saing Kim
    Se Hoon Park
    Sun Young Kyung
    Sun Jin Sym
    Sang Pyo Lee
    Jeong Woong Park
    Sung Hwan Jung
    Jinny Park
    Eun Kyung Cho
    Jae Hoon Lee
    Dong Bok Shin
    Medical Oncology, 2011, 28 : 342 - 350
  • [27] Comparison of carboplatin plus etoposide with amrubicin monotherapy for extensive-disease small cell lung cancer in the elderly and patients with poor performance status
    Igawa, Satoshi
    Shirasawa, Masayuki
    Ozawa, Takahiro
    Nishinarita, Noriko
    Okuma, Yuriko
    Ono, Taihei
    Sugimoto, Ai
    Kurahayashi, Shintaro
    Sugita, Keisuke
    Sone, Hideyuki
    Fukui, Tomoya
    Mitsufuji, Hisashi
    Kubota, Masaru
    Katagiri, Masato
    Sasaki, Jiichiro
    Naoki, Katsuhiko
    THORACIC CANCER, 2018, 9 (08) : 967 - 973
  • [28] A PHASE II STUDY OF AMRUBICIN AND TOPOTECAN COMBINATION THERAPY IN PATIENTS WITH RELAPSED OR EXTENSIVE-DISEASE SMALL-CELL LUNG CANCER: OKAYAMA LUNG CANCER STUDY GROUP TRIAL 0401
    Nogami, Naoyuki
    Kozuki, Toshiyuki
    Shinkai, Tetsu
    Katou, Yuka
    Hotta, Katsuyki
    Takigawa, Nagio
    Tabata, Masahiro
    Kiura, Katsuyuki
    Tanimoto, Mitsune
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S643 - S644
  • [29] A phase II study of amrubicin and topotecan combination therapy in patients with relapsed or extensive-disease small-cell lung cancer: Okayama Lung Cancer Study Group Trial 0401
    Nogami, Naoyuki
    Hotta, Katsuyuki
    Kuyama, Shoichi
    Kiura, Katsuyuki
    Takigawa, Nagio
    Chikamori, Kenichi
    Shibayama, Takuo
    Kishino, Daizo
    Hosokawa, Shinobu
    Tamaoki, Akihiko
    Harita, Shingo
    Tabata, Masahiro
    Ueoka, Hiroshi
    Shinkai, Tetsu
    Tanimoto, Mitsune
    LUNG CANCER, 2011, 74 (01) : 80 - 84
  • [30] A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive-disease small cell lung cancer
    Salgia, Ravi
    Stille, John R.
    Weaver, R. Waide
    McCleod, Michael
    Hamid, Oday
    Polzer, John
    Roberson, Stephanie
    Flynt, Amy
    Spigel, David R.
    LUNG CANCER, 2017, 105 : 7 - 13
12345